Bristol Myers Squibb announced that the US Food and Drug Administration (FDA) has approved label updates for both of its CAR T cell therapies, Breyanzi (lisocabtagene maraleucel; liso-cel) for the ...

Bristol Myers (BMY) receives FDA approval for label updates for Breyanzi and Abecma, that can ease access to the cancer cell therapies. Read more here.

In modern immunotherapy, modified immune cells are introduced into the body to attack tumors and other targets. Researchers at the Technical University of Munich (TUM) have developed a method for ...

Blue Label Telecoms, the majority shareholder of Cell C, is mulling the possible listing of the mobile operator on the Johannesburg Stock Exchange (JSE) as it restructures its business.

LANSING, Mich. — As the average American consumes 327 pounds of meat annually, the future of meat production is poised for transformation with the advent of cultivated cell meat State ...

Blue Label celebrates Cell C licence transfer approval By Admire Moyo, ITWeb news editor.Johannesburg, 24 Jan 2025Blue Label has a non-controlling 49.5% stake in Cell C, and is looking to get an ...

The FDA has approved updated drug labeling for Sandoz in the treatment of B-cell chronic lymphocytic leukemia. The FDA has approved an updated drug labeling for Sandoz's fludarabine phosphate ...

Nov 19, 2024 Labeling cell particles with barcodes (Nanowerk News) Cell-to-cell communication through nanosized particles, working as messengers and carriers, can now be analyzed in a whole new way, ...

Phase 2 open label, multicenter study evaluating CRG-022, a CD22-directed autologous CAR T-cell therapy, in patients (pts) with relapsed/refractory (R/R) large B-cell lymphoma (LBCL) after ...

Roche said Monday that its bispecific T cell engager Columvi improved survival in a Phase III lymphoma trial, clearing the drugmaker to seek a full, expanded label that could drive sales growth.

In this article, the role of the Incucyte® Live-Cell Analysis System is explored in the context ofmulti-spheroid live cell analysis.